PT Kalbe Farma Tbk
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more
PT Kalbe Farma Tbk (PTKFF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, PT Kalbe Farma Tbk (PTKFF) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($893.26 Billion) by net assets ($24.67 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PT Kalbe Farma Tbk - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how PT Kalbe Farma Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PT Kalbe Farma Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PT Kalbe Farma Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Weigao Group Medical Polymer Company Limited
F:UK2
|
0.022x |
|
Peker Gayrimenkul Yatirim Ortakligi AS
IS:PEKGY
|
0.126x |
|
Fujian Funeng Co Ltd
SHG:600483
|
0.078x |
|
Sally Beauty Holdings Inc
NYSE:SBH
|
0.113x |
|
Killam Apartment Real Estate Investment Trust
TO:KMP-UN
|
0.017x |
|
Progyny Inc
NASDAQ:PGNY
|
0.105x |
|
Zeon Corporation
PINK:ZEOOY
|
0.021x |
|
Technogym SpA
LSE:0RG1
|
0.040x |
Annual Cash Flow Conversion Efficiency for PT Kalbe Farma Tbk (2005–2024)
The table below shows the annual cash flow conversion efficiency of PT Kalbe Farma Tbk from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $24.59 Trillion | $4.79 Trillion | 0.195x | +54.74% |
| 2023-12-31 | $23.12 Trillion | $2.91 Trillion | 0.126x | -26.28% |
| 2022-12-31 | $22.10 Trillion | $3.77 Trillion | 0.171x | +28.37% |
| 2021-12-31 | $21.27 Trillion | $2.83 Trillion | 0.133x | -42.38% |
| 2020-12-31 | $18.28 Trillion | $4.21 Trillion | 0.231x | +53.92% |
| 2019-12-31 | $16.71 Trillion | $2.50 Trillion | 0.150x | -17.30% |
| 2018-12-31 | $15.29 Trillion | $2.77 Trillion | 0.181x | +25.33% |
| 2017-12-31 | $13.89 Trillion | $2.01 Trillion | 0.145x | -16.59% |
| 2016-12-31 | $12.46 Trillion | $2.16 Trillion | 0.173x | -22.85% |
| 2015-12-31 | $10.94 Trillion | $2.46 Trillion | 0.225x | -4.79% |
| 2014-12-31 | $9.82 Trillion | $2.32 Trillion | 0.236x | +116.28% |
| 2013-12-31 | $8.50 Trillion | $927.16 Billion | 0.109x | -41.58% |
| 2012-12-31 | $7.37 Trillion | $1.38 Trillion | 0.187x | -17.44% |
| 2011-12-31 | $6.52 Trillion | $1.47 Trillion | 0.226x | +13.15% |
| 2010-12-31 | $5.77 Trillion | $1.15 Trillion | 0.200x | -29.78% |
| 2009-12-31 | $4.79 Trillion | $1.36 Trillion | 0.285x | +53.10% |
| 2008-12-31 | $4.34 Trillion | $807.70 Billion | 0.186x | +105.77% |
| 2007-12-31 | $4.02 Trillion | $362.90 Billion | 0.090x | -50.02% |
| 2006-12-31 | $3.54 Trillion | $640.61 Billion | 0.181x | +15.14% |
| 2005-12-31 | $2.81 Trillion | $441.37 Billion | 0.157x | -- |